Serum Neurofilament Light Chain Level as an Indicator of Axonal Injury in Parsonage–Turner Syndrome (Neuralgic Amyotrophy)
Journal of the Peripheral Nervous System · 2025-12 · 30 (4)
DOI: 10.1111/jns.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 29.09.2025. Verfasst von Sophie C Queler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging, Hospital for Special Surgery, New York, New York, USA. Hauptthemen laut MEDLINE: Brachial Plexus Neuritis, Neurofilament Proteins, Axons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background and Aims Parsonage–Turner syndrome (PTS), also known as neuralgic amyotrophy, is a peripheral neuropathy resulting in severe axonal loss. This study aimed to characterize initial elevation and longitudinal trends of serum neurofilament light chain (sNfL), a marker of neuro‐axonal damage, in PTS.
Methods
This prospective cohort included 29 adults with electromyography (EMG)–confirmed PTS ≤ 6 months from symptom onset. Patients underwent sNfL testing and EMG at baseline (median 86 days from symptom onset) and again at 3‐ and 6‐month follow‐up intervals. Age‐ and BMI‐adjusted Z ‐scores were analyzed. Linear mixed‐effects models assessed associations between sNfL and time from onset, number of nerves involved, EMG metrics, and corticosteroid use.
Results
Mean sNfL Z ‐scores were significantly elevated (1.64, SD 1.32, p < 0.001) compared with healthy controls at 0 (1.64, p < 0.001) and 3 months (0.49, SD 1.06, p = 0.020). At 6 months, statistically significant elevations were not detected (0.39, SD 0.96, p = 0.106). sNfL declined by 0.17 Z ‐scores per month (95% CI: 0.11–0.23; p < 0.001). On EMG, the presence of nascent motor units, reflecting reinnervation, was associated with lower sNfL ( p = 0.043). Interpretation sNfL elevation was detected in PTS patients within the first 6 months from symptom onset and decreased as reinnervation ensued. These findings suggest sNfL deserves further consideration as a blood‐based biomarker for detection and monitoring of PTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Imaging, Hospital for Special Surgery, New York, New York, USA.
- Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
- Department of Physiatry, Hospital for Special Surgery, New York, New York, USA.
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Queler, S. C., Tsoon Tan, E., Green, A., Milani, C., Abdelhak, A., & Sneag, D. B. (2025). Serum Neurofilament Light Chain Level as an Indicator of Axonal Injury in Parsonage–Turner Syndrome (Neuralgic Amyotrophy). Journal of the Peripheral Nervous System, 30(4). https://doi.org/10.1111/jns.70063
Vancouver
Queler SC, Tsoon Tan E, Green A, Milani C, Abdelhak A, Sneag DB. Serum Neurofilament Light Chain Level as an Indicator of Axonal Injury in Parsonage–Turner Syndrome (Neuralgic Amyotrophy). Journal of the Peripheral Nervous System. 2025;30(4). doi:10.1111/jns.70063
BibTeX
@article{Queler2025,
author = {Queler, Sophie C and Tsoon Tan, Ek and Green, Ari and Milani, Carlo and Abdelhak, Ahmed and Sneag, Darryl B},
title = {Serum Neurofilament Light Chain Level as an Indicator of Axonal Injury in Parsonage–Turner Syndrome (Neuralgic Amyotrophy)},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
volume = {30},
number = {4},
doi = {10.1111/jns.70063}
}
EUVIMED